ClinVar Miner

Submissions for variant NM_016247.4(IMPG2):c.2890C>T (p.Arg964Ter)

gnomAD frequency: 0.00002  dbSNP: rs267606875
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001053603 SCV001217874 pathogenic not provided 2023-10-04 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Arg964*) in the IMPG2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IMPG2 are known to be pathogenic (PMID: 20673862). This variant is present in population databases (rs267606875, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with retinitis pigmentosa or macular dystrophy (PMID: 20673862, 24876279, 30718709). ClinVar contains an entry for this variant (Variation ID: 3549). For these reasons, this variant has been classified as Pathogenic.
Dept Of Ophthalmology, Nagoya University RCV003887852 SCV004705601 pathogenic Retinal dystrophy 2023-10-01 criteria provided, single submitter research
OMIM RCV000003727 SCV000023890 pathogenic Retinitis pigmentosa 56 2010-08-13 no assertion criteria provided literature only
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet RCV000787843 SCV000926857 likely pathogenic Macular dystrophy 2018-04-01 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.